Replies to post #310305 on NorthWest Biotherapeutics Inc (NWBO)

[TiltMyBrain]

The standard AF narrative.

[marzan]

hmmm can you compare the Science too please for the benefit of the board readers here. I am sure all your examples are not on the same science. Can you do a honest one please because you care for us.

[OilPatch]

IF and that is a big IF the trail is a failure why would...

- Linda Powers make a presentation at the American Brain Tumor Association 2020 National Conference?

- NWBO buy Flaskworks?

Amonst many other things?

[skitahoe]

On IMGN the company worked with the FDA to design a trial that would quickly prove the benefit to the subset, certainly it's delaying the approval of the drug, and costing more, but not nearly what it would if a much larger trial was determined necessary. IMGN did work with the FDA and that's what was agreed on. Frankly I believe the FDA is becoming more dynamic and if the decision needed to be made today, I believe they would have approved the drug with a more limited label.

IMGN's case was no where near as strong as what NWBO's case will be if even as already has been reported, the median for the Top 100 is near 5 years. I believe that median will have grown to around 70 months and 70 patients or more will be shown to have exceeded 5 years of life after the initiation of treatment. I believe that will get the approval even if something else the FDA put in place is missed.

Gary